AML
Feature
ASTRO Pushes Return to Direct Supervision in RT: Needed or ‘Babysitting’?
But some radiation oncologists do not agree with the proposal to move back to direct in-person supervision only.
News from the FDA/CDC
FDA Removes Harmful Chemicals From Food Packaging
The “major source of dietary exposure to PFAS from food packaging” is being eliminated.
Feature
AML: Genetic Testing Unlocks Hope
For both children and adults with this deadly leukemia, genetic testing has become the key element key to life-saving therapy for this deadly...
Feature
Are Food Emulsifiers Associated With Increased Cancer Risk?
Food emulsifiers are among the most widespread food additives.
Feature
Democratic Lawmakers Press Pfizer on Chemotherapy Drug Shortages
The company, which said in May that it was working to assuage critical shortages of methotrexate, carboplatin and cisplatin, is being asked to...
Commentary
Unleashing Our Immune Response to Quash Cancer
“It’s astounding how devious cancer cells and tumor tissue can be.”
Conference Coverage
MRD status predicts transplant benefit in NPM1-mutated AML
Certain patients with NPM1-mutated acute myeloid leukemia and measurable residual disease were shown to benefit from transplantation.
Conference Coverage
This test may guide AML therapy for Black pediatric patients
New research suggests that a polygenic score can presage how well Black pediatric patients with AML will respond to treatment.
Conference Coverage
ASH 2023: Equity, Sickle Cell, and Real-Life Outcomes
Leaders of the American Society of Hematology preview hot topics and presentations on tap at their 2023 annual meeting.
News
FDA panel voices concerns over 2 lymphoma accelerated approvals
FDA’s ODAC committee pressed for resolution on whether 2 lymphoma drugs, long on the U.S. market, actually deliver significant benefits to...
From the Journals
Study confirms small blood cancer risk from CT scans
New research suggests that radiation exposure from CT scans heightens the risk of blood cancer in people under age 22.